SCHEMBL29494233

SCHEMBL29494233

CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(C)c(C(=O)N[C@H](C)c2cccc3ccccc23)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494454 0.91 — —
SCHEMBL29494417 0.90 — —
SCHEMBL29494277 0.89 — —
SCHEMBL29494254 0.89 — —
SCHEMBL29494412 0.89 — —
SCHEMBL29494390 0.88 HCRTR1 (0.50) —
SCHEMBL29494532 0.88 — —
SCHEMBL29494548 0.88 — —
SCHEMBL29494482 0.88 — —
SCHEMBL29494228 0.87 NPC1 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO claimed
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO disclosed
Send feedback